Skip to content

NOUBY

Active
Private limited companyfounded 20196 yrs activeBergense Steenweg 934-940, 1070 Anderlecht, BelgiumKBO/BCE: BE 0738.695.778
Summary

NOUBY has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €232,150 and a net result of €53,681. Equity is growing by ~27.8% per year across the filed fiscal years. Its solvency ranks better than 72% of 19338 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€283,369total assets 2025
Staff
3 FTE
Equity
€232,150
Profit
€53,681
Turnover not published (abridged schema)
Financial health
96 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 2 d early0 of 2 deeds read
Why 96+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 1.57, cash €66,746+ Figures for FY 2025 (filed 28-04-2026)+ Equity €232,150 (81.9% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Better than 65% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 100+7
equity 81.9% of total assets
Liquidity 75+14
short-term debt 17.7% · cash 23.6%
Profitability 92+20
return on assets 18.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,748 companies)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%▲ +8.8% vs 11-2024 01-2025: < 0.1%▲ +5.4% vs 12-2024 02-2025: < 0.1%● 0.0% vs 01-2025 03-2025: < 0.1%▲ +2.6% vs 02-2025 04-2025: < 0.1%▲ +7.5% vs 03-2025 05-2025: < 0.1%▲ +4.7% vs 04-2025 06-2025: < 0.1%● 0.0% vs 05-2025 07-2025: < 0.1%● 0.0% vs 06-2025 08-2025: < 0.1%● 0.0% vs 07-2025 09-2025: < 0.1%● 0.0% vs 08-2025 10-2025: < 0.1%● 0.0% vs 09-2025 11-2025: < 0.1%● 0.0% vs 10-2025 12-2025: < 0.1%▲ +6.7% vs 11-2025 01-2026: 0.1%▲ +6.3% vs 12-2025 02-2026: < 0.1%▼ -2.0% vs 01-2026 03-2026: < 0.1%▼ -2.0% vs 02-2026 04-2026: 0.1%▲ +22.4% vs 03-2026highest value 05-2026: < 0.1%▼ -55.0% vs 04-2026lowest value 06-2026: < 0.1%● 0.0% vs 05-2026lowest value 07-2026: < 0.1%● 0.0% vs 06-2026lowest value 08-2026: < 0.1%● 0.0% vs 07-2026lowest value 09-2026: < 0.1%● 0.0% vs 08-2026lowest value 10-2026: < 0.1%● 0.0% vs 09-2026lowest value
  • Sector Human health activities (NACE 86) lowers the probability
  • Liquidity: current ratio 1.57, cash €66,746 lowers the probability
  • Figures for FY 2025 (filed 28-04-2026) lowers the probability
  • Equity €232,150 (81.9% of total assets) lowers the probability
Credit up to €22,000 at 30 days acceptable
Liquidity ample (current ratio 1.57 against 1.66 in 2024; short-term debt: 17.7% and cash: 23.6% of total assets), and 18.1% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 82%, liquidity 56%, profitability 50%, growth against the median 72%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Liquidity: current ratio 1.57, cash €66,746
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Figures for FY 2025 (filed 28-04-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Equity €232,150 (81.9% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 28-04-2026, 2 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
2 d early
2024
1 d early
2023
30 d late
2022
26 d late
2021
30 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 17 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 26 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 close03-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Equity above €200,000Eq €232,150 ▲30.1%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: 5 profitable years in a rowprofit 2025: €53,681 5 years View
  • Positive: Equity rose in 2025from €178,469 to €232,150 ▲ 30.1% View
  • Total assets 20255 fiscal years filed €283,369 View

By topic

Financials

Fiscal year
2025
Total assets
€283,369
Profit
€53,681
Solvency
81.9%
Total assets▲ 8.7%
Net result
20212025
Go to Financials

Timeline

Events
11
Since
2022
Next accounts
by 30-04-2027
  1. 28-04-2026Annual accounts filed
  2. 30-09-2025Equity above €200,000
  3. 29-04-2025Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
03-12-2019
Year ends
30-09
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.